Drug Profile
Bucladesine - Daiichi Pharmaceutical
Alternative Names: Actosin; DT 5621Latest Information Update: 20 Feb 2001
Price :
$50
*
At a glance
- Originator Daiichi Pharmaceutical
- Class Cardiotonics; Nucleotides; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Skin ulcer